Les interférons de type 1 et leur fonction antivirale

Leroy, Michael; Desmecht, Daniel

Request a copy

Article (Scientific journals)

Les interférons de type 1 et leur fonction antivirale

Leroy, Michael; Desmecht, Daniel

2006 • In Annales de Médecine Vétérinaire, 150 (2), p. 73-107

Permalink
https://hdl.handle.net/2268/33555

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Leroy_AnMedVet_2006.pdf

Publisher postprint (3.34 MB)

Demander tiré à part

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

interferon; virus; innate immunity

Abstract :

[en] Type I interferons are part of the innate immune system involved in the first line defense against invasion, replication and spreading of pathogens such as viruses. Through specific membrane or intracellular receptors, virus entry induces the expression of type I interferons which stimulates the cells through an autocrine and paracrine manner. Interferons are polypeptides that stimulate cells through membrane receptors. They induce a cascade of events leading to the synthesis of many proteins some of which having specific antiviral properties. The most characterized are the MX proteins, the 2’5’ oligoadenylate synthetase/ ribonuclease L pathway and the double-stranded RNA-dependent protein kinase R system. Recently, the protein ISG20 has been involved in the specific antiviral function of type I interferons. The interferons act on multiple steps of the viral cycle including penetration, decapsidation, mRNA transcription, protein synthesis, genome replication, assembling and excretion of viral particles. Nowadays, due to their major efficiency, type I interferons are used in therapeutics against some viral infections and cancers.
[fr] Les interférons de type I sont des cytokines appartenant au système immunitaire inné. Ils constituent la première ligne de défense contre l’invasion, la multiplication et la dissémination des organismes pathogènes, notamment des virus. L’entrée du virus dans l’organisme induit, par l’intermédiaire de récepteurs membranaires ou intracellulaire, l’induction de la synthèse des interférons de type I qui sont dès lors à même de stimuler les cellules de manière autocrine et paracrine. Les interférons sont des polypeptides qui agissent par l’intermédiaire d’un récepteur de surface. Il induisent une cascade d’événements aboutissant à la synthèse de protéines dont certaines possèdent des propriétés antivirales spécifiques. Parmi celles-ci, on distingue la protéine MX, la voie 2’5’ oligoadénylate synthétase/ribonucléase L et le système de la protéine kinase R. Récemment, une protéine appelée ISG20 a été incriminée dans l’effet antiviral des interférons de type I. Face à l’infection virale, les interférons de type I sont capables d’agir à différentes étapes du cycle de multiplication virale. Ils influencent la pénétration, la décapsidation, la transcription des ARNm, la synthèse des protéines virales, la réplication du génome, l’assemblage ou le relarguage des virions. Ils constituent de ce fait une protection efficace qui de nos jours est mise à profit dans le traitement de certaines maladies d’origine virale et tumorales.

Disciplines :

Veterinary medicine & animal health
Immunology & infectious disease

Author, co-author :

Leroy, Michael; Université de Liège - ULiège > Département de Morphologie et Pathologie > Pathologie spéciale et autopsies

Desmecht, Daniel ; Université de Liège - ULiège > Département de morphologie et pathologie > Pathologie spéciale et autopsies

Language :

French

Title :

Les interférons de type 1 et leur fonction antivirale

Publication date :

2006

Journal title :

Annales de Médecine Vétérinaire

ISSN :

0003-4118

eISSN :

1781-3875

Publisher :

ULg - Université de Liège, Liège, Belgium

Volume :

150

Issue :

Pages :

73-107

Available on ORBi :

since 22 December 2009

Statistics

Number of views

152 (3 by ULiège)

Number of downloads

2 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

ADOLF G. Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) omega 1 : evidence that IFN-omega 1 is a component of human leukocyte IFN. Virology, 1990, 175, 410-417.
AKIYAMA K., SUGII S., HIROTA Y. A clinical trial of recombinant bovine interferon alpha 1 for the control of bovine respiratory disease in calves. J. Vet. Med. Sci., 1993, 55, 449-452.
AL-KHATIB K., WILLIAMS B.R.G., SILVERMAN R. H., HALFORD W., CARR D.J.J. The murine double-stranded RNA-dependent protein kinase PKR and the murine 2′,5′-oligoadenylate synthetase-dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture. Virology, 2003, 313, 126-135.
AL-KHATIB K., WILLIAMS B.R.G., SILVERMAN R.H., HALFORD W., CARR, D.J.J. Distinctive roles for 2′,5′-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta. J. Immunol., 2004, 172, 5638-5647.
ALEXOPOULOU L., HOLT A.C., MEDZHITOV R., FLAVELL R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature, 2001, 413, 732-738.
ANDERSSON I., BLADH L., MOUSAVI-JAZI M., MAGNUSSON K., LUNDKVIST A., HALLER O., MIRAZIMI A. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J. Virol., 2004, 78, 4323-4329.
ARNHEITER H., FRESE M., KAMBADUR R., MEIER E., HALLER O. Mx transgenic mice-animal models of health. Curr. Top. Microbiol. Immunol., 1996, 206, 119-47.
ARNHEITER H., HALLER O. Mx gene control of interferon action : different kinetics of the antiviral state against influenza virus and vesicular stomatitis virus. J. Virol., 1983, 47, 626-630.
ATREYA P.L., KULKARNI S. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology, 1999, 261, 227-241.
AU W. C., MOORE P.A., LAFLEUR D.W., TOMBAL B., PITHA P.M. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J. Biol. Chem., 1998, 273, 29210-29217.
AU W.C., PITHA P.M. Recruitment of multiple interferon regulatory factors and histone acetyltransferase to the transcriptionally active interferon a promoters. J. Biol. Chem., 2001, 276, 41629-41637.
AU W.C., SU Y., RAJ N.B., PITHA P.M. Virus-mediated induction of interferon A gene requires cooperation between multiple binding factors in the interferon alpha promoter region. J. Biol. Chem., 1993, 268, 24032-24040.
AUSTIN B.A., JAMES C., SILVERMAN R.H., CARR D.J.J. Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection. J. Immunol., 2005, 175, 1100-1106.
BABIUK L.A., LAWMAN M.J., GIFFORD,G.A. Use of recombinant bovine alpha 1 interferon in reducing respiratory disease induced by bovine herpesvirus type 1. Antimicrob. Agents Chemother., 1987, 31, 752-757.
BAER G.M., CLEARY W.F., DÍAZ A.M., PERL D.F. Characteristics of 11 rabies virus isolates in mice : titers and relative invasiveness of virus, incubation period of infection, and survival of mice with sequelae. J. Infect. Dis., 1977, 136, 336-345.
BALACHANDRAN S., ROBERTS P.C., BROWN L.E., TRUONG H., PATTNAIK A.K., ARCHER D.R., BARBER G.N. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity, 2000, 13, 129-141.
BALDWIN S.L., POWELL T.D., SELLINS K.S., RADECKI S.V., COHEN J.J., MILHAUSEN M.J. The biological effects of five feline IFN-alpha subtypes. Vet. Immunol. Immunopathol., 2004, 99, 153-167.
BARNARD D.L., SIDWELL R.W., XIAO W., PLAYER M.R., ADAH S.A., TORRENCE P.F. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication : effects of oligonucleotide structure modifications and RNA target site selection. Antiviral Res., 1999, 41, 119-134.
BARTLETT N.W., BUTTIGIEG K., KOTENKO S.V., SMITH G.L. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J. Gen. Virol., 2005, 86, 1589-1596.
BARTON G.M., MEDZHITOV R. Linking Toll-like receptors to IFN-alpha/beta expression. Nat. Immunol., 2003, 4, 432-433.
BAUTISTA E.M., FERMAN G.S., GREGG D., BRUM M.C.S., GRUBMAN M.J., GOLDE W.T. Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J. Virol., 2005, 79 , 4838-4847.
BEHERA A.K., KUMAR M., LOCKEY R.F., MOHAPATRA S.S. 2′-5′ oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. J. Biol. Chem., 2002, 277, 25601-25608.
BEKISZ J., SCHMEISSER H., HERNANDEZ J., GOLDMAN N.D., ZOON K.C. Human interferons alpha, beta and omega. Growth Factors, 2004, 22, 243-251.
BELKOWSKI L.S., SEN G.C. Inhibition of vesicular stomatitis viral mRNA synthesis by interferons. J. Virol., 1987, 61, 653-660.
BENECH P., MORY Y., REVEL M., CHEBATH J. Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J., 1985, 4, 2249-2256.
BIELEFELDT-OHMANN, H. BABIUK L.A. Influence of interferons alpha I1 and gamma and of tumour necrosis factor on persistent infection with bovine viral diarrhoea virus in vitro. J. Gen. Virol., 1988, 69, 1399-1403.
BIRON C.A. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol., 1998, 10, 383-390.
BIRON C.A. Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr. Opin. Microbiol., 1999, 2, 374-381.
BONNET M.C., WEIL R., DAM E., HOVANESSIAN A.G., MEURS E.F. PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol. Cell. Biol., 2000, 20, 4532-4542.
BOSSERT B., CONZELMANN K. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants : a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol., 2002, 76, 4287-4293.
BOULESTIN A., SANDRES-SAUNE K., ALRIC L., PIPY B., DUBOIS M., VINEL J.-P., IZOPET J. Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin. Antivir. Ther., 2005, 10, 499-504.
BRAGANÇA J., GÉNIN P., BANDU M. T., DARRACQ N., VIGNAL M., CASSÉ C., DOLY J., CIVAS A. Synergism between multiple virus-induced factor-binding elements involved in the differential expression of interferon A genes. J. Biol. Chem., 1997, 272, 22154-22162.
BRIDGEN A., DALRYMPLE D., WEBER F., ELLIOT R. Inhibition of Dugbe nairovirus replication by human MxA protein. Virus Res., 2004, 99, 47-50.
BRYSON D.G., MCNULTY M.S., EVANS R.T., ALLAN G. Studies of the effects of recombinant human-alpha 1 interferon on experimental parainfluenza type 3 virus infections of the respiratory tract of calves. Vet. Rec., 1990, 125, 615-618.
BUKHOLM G., DEGRÉ M., WHITAKER-DOWLING P. Interferon treatment reduces endocytosis of virus and facultatively intracellular bacteria in various cell lines. J. Interferon Res., 1990, 10, 83-89.
BUKOWSKI R., ERNSTOFF M.S., GORE M.E., NEMUNAITIS J.J., AMATO R., GUPTA S.K., Tendler C.L. Pegylated interferon alfa-2b treatment for patients with solid tumors : a phase {I}/{II} study. J. Clin. Oncol., 2002, 20, 3841-3849.
BYCROFT M., GRÜNERT S., MURZIN A.G., PROCTOR M., JOHNSTON D.S. NMR solution structure of a dsRNA binding domain from Drosophila staufen protein reveals homology to the N-terminal domain of ribosomal protein S5. EMBO J., 1995, 14, 3563-3571.
CAMY G. L'interferon oméga guérit un chat calicivirus positif. Point Vét., 2003, 236 Suppl., 34-35.
CAPON D.J., SHEPARD H.M., GOEDDEL D.V. Two distinct families of human and bovine interferon-alpha genes are coordinately expressed and encode functional polypeptides. Mol. Cell. Biol., 1985, 5, 768-779.
CARR D.J.J., AL-KHATIB K., JAMES C.M., SILVERMAN R. Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J. Neuroimmunol., 2003, 141, 40-46.
CHANG T.-H., LIAO C.-L., LIN Y.-L. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect., 2006, 8, 157-171.
CHARLESTON B., STEWART H. An interferon-induced Mx protein : cDNA sequence and high-level expression in the endometrium of pregnant sheep. Gene, 1993, 137, 327-331.
CHARLIER M., L'HARIDON R., BOISNARD M., MARTAL J., GAYE P. Cloning and structural analysis of four genes encoding interferonomega in rabbit. J. Interferon Res., 1993, 13, 313-322.
CHEBATH J., BENECH P., HOVANESSIAN A., GALABRU J., REVEL M. Four different forms of interferon-induced 2′,5′-oligo(A) synthetase identified by immunoblotting in human cells. J. Biol. Chem., 1987a, 262, 3852-3857.
CHEBATH J., BENECH P., REVEL M., VIGNERON M. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature, 1987b, 330, 587-588.
CHEN J., BAIG E., FISH E. N. Diversity and relatedness among the type I interferons. J. Interferon Cytokine Res., 2004, 24, 687-698.
CHIEUX V., CHEHADEH W., HARVEY J., HALLER O., WATTRÉ P., HOBER D. Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. Virology, 2001, 283, 84-92.
CHINSANGARAM J., KOSTER M., GRUBMAN M.J. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol., 2001, 75, 5498-5503.
CHOUDHARY S., GAO J., LEAMAN D.W., DE B.P. Interferon action against human parainfluenza virus type 3 : involvement of a novel antiviral pathway in the inhibition of transcription. J. Virol., 2001, 75, 4823-4831.
CHU W. M., OSTERTAG D., LI Z. W., CHANG L., CHEN Y., HU Y., WILLIAMS B., PERRAULT J., KARIN M. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity, 1999, 11, 721-731.
CIVAS A., DION M., VODJDANI G., DOLY J. Repression of the murine interferon alpha 11 gene : identification of negatively acting sequences. Nucleic Acids Res., 1991, 19, 4497-4502.
CLEMENS M., SAFER B., MERRICK W., ANDERSON W., LONDON I. Inhibition of protein synthesis in rabbit reticulocyte lysates by double-stranded RNA and oxidized glutathione : indirect mode of action on polypeptide chain initiation. Proc. Natl. Acad. Sci. USA, 1975, 72, 1286-1290.
CLEMENS M.J. Regulation of eukaryotic protein synthesis by protein kinases that phosphorylate initiation factor eIF-2. Mol. Biol. Rep., 1994, 19, 201-210.
COCCIA E., ROMEO G., NISSIM A., MARZIALI G., ALBERTINI R., AFFABRIS E., BATTISTINI A., FIORUCCI G., ORSATTI R., ROSSI G. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology, 1990, 179, 228-233.
COHEN B., NOVICK D., BARAK S. RUBINSTEIN M. Ligand-induced association of the type I interferon receptor components. Mol. Cell. Biol., 1995, 15, 4208-4214.
COLAMONICI O., YAN H., DOMANSKI P., HANDA R., SMALLEY D., MULLERSMAN J., WITTE M., KRISHNAN K., KROLEWSKI J. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mol. Cell. Biol., 1994, 14, 8133-8142.
COLAMONICI O. R., D'ALESSANDRO F., DIAZ M. O., GREGORY S.A., NECKERS L.M., NORDAN R. Characterization of three monoclonal antibodies that recognize the interferon alpha 2 receptor. Proc. Natl. Acad. Sci. USA, 1990, 87, 7230-7234.
COLAMONICI O. R., DOMANSKI P. Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. J. Biol. Chem., 1993, 268, 10895-10899.
COLAMONICI O.R., UYTTENDAELEH.,DOMANSKI P., YAN H., KROLEWSKI J.J. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J. Biol. Chem., 1994, 269 , 3518-3522.
COLE J.L., CARROLL S.S., BLUE E. S., VISCOUNT T., KUO L.C. Activation of RNase L by 2′,5′-oligoadenylates. Biophysical characterization. J. Biol. Chem., 1997, 272, 19187-19192.
CONRADT H.S., EGGE H., PETER-KATALINIC J., REISER W., SIKLOSI T., SCHAPER K. Structure of the carbohydrate moiety of human interferon-beta secreted by a recombinant Chinese hamster ovary cell line. J. Biol. Chem., 1987, 262, 14600-14605.
CONSTANTINESCU S. N., CROZE E., WANG C., MURTI A., BASU L., MULLERSMAN J.E., PFEFFER L.M. Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex. Proc. Natl. Acad. Sci. USA, 1994, 91, 9602-9606.
CRAIG A.W., COSENTINO G.P., DONZÉ O., SONENBERG N. The kinase insert domain of interferon-induced protein kinase PKR is required for activity but not for interaction with the pseudosubstrate K3L. J. Biol. Chem., 1996, 271, 24526-24533.
CRANCE J.M., LÉVÊQUE F., CHOUSTERMAN S., JOUAN A., TRÉPO C., DELOINCE R. Antiviral activity of recombinant interferonalpha on hepatitis A virus replication in human liver cells. Antiviral Res., 1995, 28 , 69-80.
CRESPI M., CHIU M.N., SCHOUB B.D., LYONS S.F. Effect of interferon on Vero cells persistently infected with SSPE virus and lytically infected with measles virus. Arch. Virol., 1986, 90, 87-96.
CUMMINS J.M., GUTHRIE D., HUTCHESOND.P.,KRAKOWKA S., ROSENQUIST B.D. Natural human interferon alpha administrated orally as a treatment of bovine respiratory disease complex. J. Interferon Cytokine Res., 1999, 19, 907-910.
CUMMINS J.M., HUTCHESON D.P., CUMMINS M.J., GEORGIADES J.A., RICHARDS A.B. Oral therapy with human interferon alpha in calves experimentally injected with infectious bovine rhinotracheitis virus. Arch. Immunol. Ther. Exp., 1993, 41, 193-197.
CUMMINS J.M., MOCK R.E., SHIVE B.W., KRAKOWKA S., RICHARDS A.B., HUTCHESON D.P. Oral treatment of transmissible gastroenteritis with natural human interferon alpha: a field study. Vet. Immunol. Immunopathol., 1995, 45, 355-360.
CUMMINS J.M., TOMPKINS M.B., OLSEN R.G., TOMPKINS W.A., LEWIS M.G. Oral use of human alpha interferon in cats. J. Biol. Response Mod., 1988, 7, 513-523.
CUSSON-HERMANCE N., KHURANA S., LEE T.H., FITZGERALD K.A., KELLIHER M.A. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-kappaB activation but does not contribute to interferon regulatory factor 3 activation. J. Biol. Chem., 2005, 280, 36560-36566.
CZARNIECKI C.W., ALLEN P.T. Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells. Antiviral Res., 1984, 4, 351-355.
DE CLERCQ E., DE SOMER P. Comparative study of the efficacy of different forms of interferon therapy in the treatment of mice challenged intranasaly with vesicular stomatitis virus (VSV). Proc. Soc. Exp. Biol. Med., 1971, 138, 301-307.
DÍAZ M.O., POMYKALA H.M., BOHLANDER S.K., MALTEPE E., MALIK K., BROWNSTEIN B., OLOPADE O. I. Structure of the human type-I interferon gene cluster determined from a YAC clone contig. Genomics, 1994, 22, 540-552.
DE MARI K., MAYNARD L., SANQUER A., LEBREUX B., EUN H.M. Therapeutic effects of recombinant feline interferon-omega on feline leukemiavirus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J. Vet. Intern. Med., 2004, 18, 477-482.
DEMMERS K.J., KALUZ S., DEAKIN D. W., JABBOUR H.N., FLINT A.P. Production of interferon by the conceptus in red deer Cervus elaphus. J. Reprod. Fertil., 1999, 115, 59-65.
DENNIS M.J., THOMAS L.H., STOTT E.J. Effects of recombinant human alpha A interferon in gnobiotic calves challenged with respiratory syncytial virus. Res. Vet. Sci., 1991, 50, 222-228.
DESAI S.Y., PATEL R.C., SEN G.C., MALHOTRA P., GHADGE G.D., THIMMAPAYA B. Activation of interferon-inducible 2′-5′ oligoadenylate synthetase by adenoviral VAI RNA. J. Biol. Chem., 1995, 270, 3454-3461.
DESLOGES N., RAHAUS M., WOLFF M.H. Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon. J. Gen. Virol., 2005, 86, 1-6.
DIAMOND M.S., HARRIS E. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology, 2001, 289, 297-311.
DIAMOND M.S., ROBERTS T.G., EDGIL D., LU B., ERNST J., HARRIS E. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J. Virol., 2000, 74, 4957-4966.
DIAZ M.O., BOHLANDER S., ALLEN G. Nomenclature of the human interferon genes. J. Interferon Cytokine Res., 1996, 16, 179-180.
DIJKEMA R., POUWELS P., DE REUS A., SCHELLEKENS H. Structure and expression in Escherichia coli of a cloned rat interferon-alpha gene. Nucleic Acids Res., 1984, 12, 1227-1242.
DOMANSKI P., COLAMONICI O.R. The type-I interferon receptor. The long and short of it. Cytokine Growth Factor Rev., 1996, 7, 143-151.
DOMANSKI P., WITTE M., KELLUM M., RUBINSTEIN M., HACKETT R., PITHA P., COLAMONICI O.R. Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling. J. Biol. Chem., 1995, 270, 21606-21611.
DU W., THANOS D., MANIATIS T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell, 1993, 74, 887-898.
DURBIN J.E., FERNANDEZ-SESMA A., LEE C.K., RAO T.D., FREY A.B., MORAN T.M., VUKMANOVIC S., GARCIA-SASTRE A., LEVY D.E. Type I IFN modulates innate and specific antiviral immunity. J. Immunol., 2000, 164 , 4220-4228.
ELLERMANN-ERIKSEN S., JUSTESEN J., MOGENSEN S.C. Genetically determined difference in the antiviral action of alpha/beta interferon in cells from mice resistant or susceptible to herpes simplex virus type 2. J. Gen. Virol., 1986, 67, 1859-1866.
ENDO T. A., MASUHARA M., YOKOUCHI M., SUZUKI R., SAKAMOTO H., MITSUI K., MATSUMOTO A., TANIMURA S., OHTSUBO M., MISAWA H., MIYAZAKI T., LEONOR N., TANIGUCHI T., FUJITA T., KANAKURA Y., KOMIYA S., YOSHIMURA A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 1997, 387, 921-924.
ESPERT L., DEGOLS G., GONGORA C., BLONDEL D., WILLIAMS B., SILVERMAN R., MECHTI N. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem., 2003, 278, 16151-16158.
ESPERT L., DEGOLS G., LIN Y.-L., VINCENT T., BENKIRANE M., MECHTI N. Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. J. Gen. Virol., 2005, 86, 2221-2229.
ESPERT L., REY C., GONZALEZ L., DEGOLS G., CHELBI-ALIX M., MECHTI N., GONGORA C. The exonuclease ISG20 is directly induced by synthetic dsRNA via NF-kappaB and IRF1 activation. Oncogene, 2004, 23, 4636-4640.
FALTYNEK C., MCCANDLESS S., CHEBATH J., BAGLIONI C. Different mechanisms for activation of gene transcription by interferons alpha and gamma. Virology, 1985, 144, 173-180.
FALVO J., THANOS D., MANIATIS T. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell, 1995, 83, 1101-1111.
FARR B.M., GWALTNEY J.M., ADAMS K.F., HAYDEN F.G. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds. Antimicrob Agents Chemother., 1984, 26, 31-34.
FITZGERALD K.A., ROWE D.C., BARNES B.J., CAFFREY D.R., VISINTIN A., LATZ E., MONKS B., PITHA P. M., GOLENBOCK D.T. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIP. J. Exp. Med., 2003, 198, 1043-1055.
FLODSTRÖM-TULLBERG M., HULTCRANTZ M., STOTLAND A., MADAY A., TSAI D., FINE C., WILLIAMS B., SILVERMAN R., SARVETNICK N. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J. Immunol., 2005, 174, 1171-1177.
FLOHR F., SCHNEIDER-SCHAULIES S., HALLER O., KOCHS G. The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett., 1999, 463, 24-28.
FRESE M., KOCHS G., FELDMANN H., HERTKORN C., HALLER O. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol., 1996, 70, 915-923.
FRESE M., PIETSCHMANN T., MORADPOUR D., HALLER O., BARTENSCHLAGER R. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J. Gen. Virol., 2001, 82, 723-733.
FRESE M., WEEBER M., WEBER F., SPETH V., HALLER O. Mx1 sensitivity : Batken virus is an orthomyxovirus closely related to Dhori virus. J. Gen. Virol., 1997, 78, 2453-2458.
FRIEDMAN R.L., STARK G.R. alpha-Interferon-inducedtranscription of HLA and metallothionein genes containing homologous upstreamsequences. Nature, 1985, 314, 637-639.
FUJISAWA J., IWAKURA Y., KAWADE Y. Nonglycosylated mouse L cell interferon produced by the action of tunicamycin. J. Biol. Chem., 1978, 253, 8677-8679.
FUJITA T., KIMURA Y., MIYAMOTO M., BARSOUMIAN E. L., TANIGUCHI T. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature, 1989, 337, 270-272.
FUJITA T., SAKAKIBARA J., SUDO Y., MIYAMOTO M., KIMURA Y., TANIGUCHI T. Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J., 1988, 7, 3397-3405.
FULTON R.W., BURGE L.J., MCCRAKEN J.S. Effect of recombinant DNA-derived bovine and human interferons on replication of bovine herpesvirus-1, parainfluenza-3, and respiratory syncytial viruses. Am. J. Vet. Res., 1986, 47, 751-753.
FULTON R.W., DOWNING M.M., CUMMINS J.M. Antiviral effects of bovine interferons on bovine respiratory tract viruses. J. Clin. Microbiol., 1984, 19, 492-497.
GALABRU J., KATZE M.G., ROBERT N., HOVANESSIAN A.G. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur. J. Biochem., 1989, 178, 581-589.
GALE M., BLAKELY C.M., KWIECISZEWSKI B., TAN S.L., DOSSETT M., TANG N.M., KORTH M.J., POLYAK S.J., GRETCH D. R., KATZE M.G. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein : molecular mechanisms of kinase regulation. Mol. Cell. Biol., 1998, 18, 5208-5218.
GALE M.J., KORTH M.J., TANG N.M., TAN S.L., HOPKINS D.A., DEVER T.E., POLYAK S.J., GRETCH D.R., KATZE M.G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the non-structural 5A protein. Virology, 1997, 230, 217-227.
GARCIA-SASTRE A., DURBIN R., ZHENG H., PALESE P., GERTNER R., LEVY D., DURBIN J. The role of interferon in influenza virus tissue tropism. J. Virol., 1998, 72, 8550-8558.
GAUZZI M.C., VELAZQUEZ L., MCKENDRY R., MOGENSEN K.E., FELLOUS M., PELLEGRINI S. Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J. Biol. Chem., 1996, 271, 20494-20500.
GHISLAIN J., SUSSMAN G., GOELZ S., LING L. E., FISH E. N. Configuration of the interferon-alpha/beta receptor complex determines the context of the biological response. J. Biol. Chem., 1995, 270, 21785-21792.
GHOSHA., SARKAR S.N., SEN G.C. Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase. Virology, 2000, 266, 319-328.
GILLESPIE J.H., ROBSON D.S., SCOTT F.W., SCHIFF E.I. In vitro protective effect of bacteria-derived bovine alpha interferon 11 against selected bovine viruses. J. Clin. Microbiol., 1985, 22, 912-914.
GNATEK G.G., SMITH L.D., DUBY R.T., GODKIN J.D. Maternal recognition of pregnancy in the goat : effects of conceptus removal on interestrus intervals and characterization of conceptus protein production during early pregnancy. Biol. Reprod., 1989, 41, 655-663.
GÉNIN P., BRAGANÇA J., DARRACQ N., DOLY J., CIVAS A. A novel PRD I and TG binding activity involved in virus-induced transcription of IFN-A genes. Nucleic Acids Res., 1995, 23, 5055-5063.
GODKIN J.D., BAZER F.W., ROBERTS R.M. Ovine trophoblast protein 1, an early secreted blastocyst protein, binds specifically to uterine endometrium and affects protein synthesis. Endocrinology, 1984, 114, 120-130.
GOEDDEL D.V., LEUNG D.W., DULL T.J., GROSS M., LAWN R.M., MCCANDLISS R., SEEBURG P.H., ULLRICH A., YELVERTON E., GRAY P.W. The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature, 1981, 290, 20-26.
GOLOMB H.M. The treatment of hairy cell leukemia. Blood, 1987, 69, 979-983.
GONGORA C., DAVID G., PINTARD L., TISSOT C., HUA T., DEJEAN A., MECHTI N. Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem., 1997, 272, 19457-19463.
GOODBOURN S., DIDCOCK L., RANDALL R.E. Interferons : cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol., 2000, 81, 2341-2364.
GORDIEN E., ROSMORDUC O., PELTEKIAN C., GARREAU F., BRECHOT C., KREMSDORF D. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J. Virol., 2001, 75, 2684-2691.
GREEN S.R., MATHEWS M.B. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev., 1992, 6, 2478-2490.
GRESSER I. Biologic effects of interferons. J. Invest. Dermatol., 1990, 95, 66S-71S.
GRIEDER F.B., VOGEL S.N. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology, 1999, 257, 106-118.
GUERRERO-PLATA A., BARON S., POAST J.S., ADEGBOYEGA P.A., CASOLA A., GAROFALO R.P. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J. Virol., 2005, 79, 10190-10199.
GUILLOT L., GOFFIC R. L., BLOCH S., ESCRIOU N., AKIRA S., CHIGNARD M., SI-TAHAR M. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem., 2005, 280, 5571-5580.
GUTTERMAN J.U. Cytokine therapeutics : lessons from interferon alpha. Proc. Natl. Acad. Sci. USA, 1994, 91, 1198-1205.
HALLER O., ARNHEITER H., GRESSER I., LINDENMANN J. Genetically determined, interferon-dependent resistance to influenza virus in mice. J. Exp. Med., 1979, 149, 601-612.
HALLER O., FRESE M., KOCHS G. Mx proteins : mediators of innate resistance to RNA viruses. Rev. Sci. Tech., 1998, 17, 220-230.
HALLER O., FRESE M., ROST D., NUTTALL P., KOCHS G. Tick-borne thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J. Virol., 1995, 69, 2596-2601.
HALLER O., KOCHS G. Interferon-induced mx proteins : dynamin-like GTPases with antiviral activity. Traffic, 2002, 3, 710-717.
HARDY M., OWCZAREK C., JERMIIN L., EJDEBACK M., HERTZOG P. Characterization of the type I interferon locus and identification of novel genes. Genomics, 2004, 84, 331-345.
HARTMANN R., NORBY P.L., MARTENSENP.M.,JORGENSEN P., JAMES M.C., JACOBSEN C., MOESTRUP S.K., CLEMENS M.J., JUSTESEN J. Activation of 2′-5′ oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers. J. Biol. Chem., 1998, 273, 3236-3246.
HAUPTMANN R., SWETLY P. A novel class of human type I interferons. Nucleic Acids Res., 1985, 13, 4739-4749.
HAYNES L.M., MOORE D.D., KURT-JONES E.A., FINBERG R.W., ANDERSON L.J., TRIPP R.A. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol., 2001, 75, 10730-10737.
HEFTI H.P., FRESE M., LANDIS H., DI PAOLO C., AGUZZI A., HALLER O., PAVLOVIC J. Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J. Virol., 1999, 73, 6984-6991.
HEIM A., GRUMBACH I., PRINGAKERBLOM P., STILLESIEGENER M., MÜLLER G., KANDOLF R., FIGULLA, H.R. Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha. Antiviral Res., 1997, 34, 101-111.
HELMER S.D., HANSEN P.J., ANTHONY R.V., THATCHER W.W., BAZER F.W., ROBERTS R.M. Identification of bovine trophoblast protein-1, a secretory protein immunologically related to ovine trophoblast protein-1. J. Reprod. Fertil., 1987, 79, 83-91.
HIGASHI Y., SOKAWA Y., WATANABE Y., KAWADE Y., OHNO S., TAKAOKA C., TANIGUCHI T. Structure and expression of a cloned cDNA for mouse interferon-beta. J. Biol. Chem., 1983, 258, 9522-9529.
HIJIKATA M., OHTA Y., MISHIRO S. Identification of a single nucleotide polymorphism in theMxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon. Intervirology, 2000, 43, 124-127.
HILFENHAUS J., WEINMANN E., MAJER M., BARTH R., JAEGER O. Administration of human interferon to rabies virus-infected monkeys after exposure. J. Infect. Dis., 1977, 135, 846-849.
HIMMLER A., HAUPTMANN R., ADOLF G. R., SWETLY P. Molecular cloning and expression in Escherichia coli of equine type I interferons. DNA, 1986, 5, 345-356.
HIMMLER A., HAUPTMANN R., ADOLF G. R., SWETLY P. Structure and expression in Escherichia coli of canine interferon-alpha genes. J. Interferon Res., 1987, 7, 173-183.
HISCOTT J., CANTELL K., WEISSMANN C. Differential expression of human interferon genes. Nucleic Acids Res., 1984, 12, 3727-3746.
HO C.K., CHEN H.Y., PERNG R.J., LAI J.L. Susceptibility of different leukemic cell lines to the anticellular and antiviral effects of interferons. Proc. Natl. Sci. Counc. Repub. China B, 1985, 9, 235-238.
HOBBS D.S., PESTKA S. Purification and characterization of interferons from a continuous myeloblastic cell line. J. Biol. Chem., 1982, 257, 4071-4076.
HONDA K., YANAI H., NEGISHI H., ASAGIRI M., SATO M., MIZUTANI T., SHIMADA N., OHBA Y., TAKAOKA A., YOSHIDA N., TANIGUCHI T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature, 2005a, 434, 772-777.
HONDA K., YANAI H., TAKAOKA A., TANIGUCHI T. Regulation of the type I IFN induction : a current view. Int. Immunol., 2005b, 17, 1367-1378.
HONDA Y., KAWAI A. MATSUMOTO S. Comparative studies of rabies and Sindbis virus replication in human neuroblastoma (SYM-I) cells that can produce interferon. J. Gen. Virol., 1984, 65, 1645-1653.
HOOPER D. C., MORIMOTO K., BETTE M., WEIHE E., KOPROWSKI H., DIETZSCHOLD B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol., 1998, 72, 3711-3719.
HORISBERGER M., STAEHELI P., HALLER O. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl. Acad. Sci. USA, 1983, 80, 1910-1914.
HORVATH C.M., STARK G.R., KERR I.M., DARNELL J.E. Interactions between STAT and non-STAT proteins in the interferonstimulated gene factor 3 transcription complex. Mol. Cell. Biol., 1996, 16, 6957-6964.
HOSS-HOMFELD A., ZWARTHOFF E.C., ZAWATZKY R. Cell type specific expression and regulation of murine interferon alpha and beta genes. Virology, 1989, 173, 539-550.
HOUGHTON M., JACKSON I.J., PORTER A.G., DOEL S.M., CATLIN G.H., BARBER C., CAREY N.H. The absence of introns within a human fibroblast interferon gene. Nucleic Acids Res., 1981, 9, 247-266.
HOVANESSIAN A., BROWN R., KERR I. Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferontreated cells. Nature, 1977, 268, 537-540.
HOVANESSIAN A., MEURS E., AUJEAN O., VAQUERO C., STEFANOS S., FALCOFF E. Antiviral response and induction of specific proteins in cells treated with immune T (type II) interferon analogous to that from viral interferon (type I)-treated cells. Virology, 1980, 104, 195-204.
HOVNANIAN A., REBOUILLAT D., MATTEI M. G., LEVY E.R., MARIE I., MONACO A.P., HOVANESSIAN A.G. The human 2′,5′-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms. Genomics, 1998, 52, 267-277.
HUNTER T., HUNT T., JACKSON R., ROBERTSON H. The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. J. Biol. Chem., 1975, 250, 409-417.
HWANG S.Y., HERTZOG P.J., HOLLAND K.A., SUMARSONO S.H., TYMMS M.J., HAMILTON J.A., WHITTY G., BERTONCELLO I., KOLA I. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. USA, 1995, 92, 11284-11288.
IANNUZZI L., GALLAGHER D.S., RYAN A.M., MEO G.P.D., WOMACK J.E. Chromosomal localization of omega and trophoblast interferon genes in cattle and river buffalo by sequential R-banding and fluorescent in situ hybridization. Cytogenet. Cell. Genet., 1993a, 62, 224-227.
IANNUZZI L., MEO G.P.D., GALLAGHER D.S., RYAN A.M., FERRARA L., WOMACK J.E. Chromosomal localization of omega and trophoblast interferon genes in goat and sheep by fluorescent in situ hybridization. J. Hered., 1993b, 84, 301-304.
IDA-HOSONUMA M., IWASAKI T., YOSHIKAWA T., NAGATA N., SATO Y., SATA T., YONEYAMA M., FUJITA T., TAYA C., YONEKAWA H., KOIKE S. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol., 2005, 79, 4460-4469.
IMAKAWA K., ANTHONY R.V., KAZEMI M., MAROTTI K.R., POLITES H.G., ROBERTS R.M. Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm. Nature, 1987, 330, 377-379.
IORDANOV M.S., PARANJAPE J.M., ZHOU A., WONG J., WILLIAMS B.R., MEURS E.F., SILVERMAN R.H., MAGUN B.E. Activation of p38mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus : involvement of RNase L, protein kinase R, and alternative pathways. Mol. Cell. Biol., 2000, 20, 617-627.
ISAACS A., LINDENMANN J. Virus interference : the interferon. Proc. R. Soc. Med., 1957, 147, 258-267.
ISAACS A., LINDENMANN J., VALENTINE R.C. Virus interference. II. Some properties of interferon. Proc. R. Soc. Lond. B. Biol. Sci., 1957, 147, 268-273.
ISHIDA T., SHIBANAI A., TANAKA S., UCHIDA K., MOCHIZUKI M. Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis. J. Feline Med. Surg., 2004, 6, 107-109.
JACKSON A.C. Rabies virus infection : an update. J. Neurovirol., 2003, 9, 253-258.
JEFFREY I.W., KADEREIT S., MEURS E.F., METZGER T., BACHMANNM., SCHWEMMLE M., HOVANESSIAN A.G., CLEMENS M.J. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp. Cell. Res., 1995, 218, 17-27.
JAROSINSKI K.W., JIA W., SEKELLICK M.J., MARCUS P.I., SCHAT K.A. Cellular responses in chickens treated with IFN-alpha orally or inoculated with recombinant Marek's disease virus expressing IFN-alpha. J. Interferon Cytokine Res., 2001, 21, 287-296.
JIANG Z., ZAMANIAN-DARYOUSH M., NIE H., SILVA A.M., WILLIAMS B.R.G., LI X. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR . J. Biol. Chem., 2003, 278, 16713-16719.
JIMÉNEZ-GARCÍA L.F., GREEN S.R., MATHEWS M.B., SPECTOR D.L. Organization of the double-stranded RNA-activated protein kinase DAI and virus-associated VA RNAI in adenovirus-2-infected HeLa cells. J. Cell. Sci., 1993, 106, 11-22.
JOHANNES L., ARNHEITER H., MEIER E. Switch in antiviral specificity of a GTPase upon translocation from the cytoplasm to the nucleus. J. Virol., 1993, 67, 1653-1657.
JOHNSTON D.S., BROWN N.H., GALL J.G., JANTSCH M. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA, 1992, 89, 10979-10983.
JUSTE R.A., OTT T.L., KWANG J., BAZER F.W., DE LA CONCHA-BERMEJILLO A. Effects of recombinant interferon-tau on ovine lentivirus replication. J. Interferon Cytokine Res., 1996, 16, 989-994.
JUSTE R.A., OTT T.L., KWANG J., BAZER F.W., DE LA CONCHA-BERMEJILLO A. Effects of recombinant ovine interferon-tau on ovine lentivirus replication and progression of disease. J. Gen. Virol., 2000, 81, 525-532.
KANERVA M., MELEN K., VAHERI A., JULKUNEN I. Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein. Virology, 1996, 224, 55-62.
KARIN M., BEN-NERIAH Y. Phosphorylation meets ubiquitination : the control of NF-[kappa]B activity. Annu. Rev. Immunol., 2000, 18, 621-63.
KARIN M., DELHASE M. The I kappa B kinase (IKK) and NF-kappa B : key elements of proinflammatory signalling. Semin. Immunol., 2000, 12, 85-98.
KARPUSAS M., NOLTE M., BENTON C. B., MEIER W., LIPSCOMB W. N., GOELZ S. The crystal structure of human interferon beta at 2.2-A resolution. Proc. Natl. Acad. Sci. USA, 1997, 94, 11813-11818.
KERR I., BROWN R. pppA2′p5′A2′p5′A : an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA, 1978, 75, 256-260.
KHABAR K.S., DHALLA M., SIDDIQUI Y., ZHOU A., ALAHDAL M.N., DER S.D., SILVERMAN R.H., WILLIAMS B.R. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L : HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res., 2000, 20, 653-659.
KIM T., KIM T.Y., LEE W.G., YIM J., KIM T.K. Signaling pathways to the assembly of an interferon-beta enhanceosome. Chemical genetic studies with a small molecule. J. Biol. Chem., 2000, 275, 16910-16917.
KIM T.K., MANIATIS T. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. Mol. Cell., 1997, 1, 119-129.
KNAPP S., YEE L.J., FRODSHAM A.J., HENNIG B.J.W., HELLIER S., ZHANG L., WRIGHT M., CHIARAMONTE M., GRAVES M., THOMAS H.C., HILL A.V.S., THURSZ M.R. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection : roles of MxA, OAS-1 and PKR. Genes Immun., 2003, 4, 411-419.
KNIGHT E. Heterogeneity of purified mouse interferons. J. Biol. Chem., 1975, 250, 4139-4144.
KO J., JIN H., ASANO A., TAKADA A., NINOMIYA A., KIDA H., HOKIYAMA H., OHARA M., TSUZUKI M., NISHIBORI M., MIZUTANI M., WATANABE T. Polymorphisms and the differential antiviral activity of the chicken Mx gene. Genome Res., 2002, 12, 595-601.
KO J., TAKADA A., MITSUHASHI T., AGUI T., WATANABE T. Native antiviral specificity of chicken Mx protein depends on amino acid variation at position 631. Anim. Genet., 2004, 35, 119-122.
KOBAYASHI S. Titration of interferon using a new type VSV (New Jersey serotype). Uirusu, 1974, 24, 1-7.
KOCHS G., HALLER O. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc. Natl. Acad. Sci. USA, 1999a, 96, 2082-2086.
KOCHS G., HALLER O. GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae). J. Biol. Chem., 1999b, 274, 4370-4376.
KOCHS G., JANZEN C., HOHENBERG H., HALLER O. Antivirally active MxA protein Sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc. Natl. Acad. Sci. USA, 2002, 99, 3153-3158.
KOSTURA M., MATHEWS M.B. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol. Cell. Biol., 1989, 9, 1576-1586.
KOTENKO S.V., GALLAGHER G., BAURIN V.V., LEWIS-ANTES A., SHEN M., SHAH N.K., LANGER J.A., SHEIKH F., DICKENSHEETS H., DONNELLY R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol., 2003, 4, 69-77.
KRISHNAN K., YAN H., LIM J.T., KROLEWSKI J.J. Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation. Oncogene, 1996, 13, 125-133.
KUMAR A., HAQUE J., LACOSTE J., HISCOTT J., WILLIAMS B. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. USA, 1994, 91, 6288-6292.
KUMAR K.P., MCBRIDE K.M., WEAVER B.K., DINGWALL C., REICH N.C. Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol. Cell. Biol., 2000, 20, 4159-4168.
KURT-JONES E.A., POPOVA L., KWINN L., HAYNES L.M., JONES L.P., TRIPP R.A., WALSH E.E., FREEMAN M.W., GOLENBOCK D.T., ANDERSON L.J., FINBERG R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol., 2000, 1, 398-401.
KUZEL T.M., GILYON K., SPRINGER E., VARIAKOJIS D., KAUL K., BUNN P.A., EVANS L., ROENIGK H.H., ROSEN S.T. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J. Natl. Cancer Inst., 1990, 82, 203-207.
LAFLEUR D., NARDELLI B., TSAREVA T., MATHER D., FENG P., SEMENUK M., TAYLOR K., BUERGIN M., CHINCHILLA D., ROSHKE V., CHEN G., RUBEN S., PITHA P., COLEMAN T., MOORE P. Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J. Biol. Chem., 2001, 276, 39765-39771.
LANDIS H., SIMON-JODICKE A., KLOTI A., DI PAOLO C., SCHNORR J.J., SCHNEIDER-SCHAULIES S., HEFTI H. P., PAVLOVIC J. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol., 1998, 72, 1516-1522.
LANGLAND J.O., JIN S., JACOBS B.L., ROTH D.A. Identification of a plant-encoded analog of PKR, the mammalian double-stranded RNA-dependent protein kinase. Plant. Physiol., 1995, 108, 1259-1267.
LANGLAND J.O., LANGLAND L.A., BROWNING K.S., ROTH D.A. Phosphorylation of plant eukaryotic initiation factor-2 by the plant-encoded double-stranded RNA-dependent protein kinase, pPKR, and inhibition of protein synthesis in vitro. J. Biol. Chem., 1996, 271, 4539-4544.
LARSEN R., ROKENES T., ROBERTSEN B. Inhibition of infectious pancreatic necrosis virus replication by atlantic salmon Mx1 protein. J. Virol., 2004, 78, 7938-7944.
LAURENCE L., ROUX D., CAILLA H., RIVIERE Y., MARCOVISTZ R., HOVANESSIAN A. Comparison of the effects of rabies virus infection and of combined interferon and poly(I).poly(C) treatment on the levels of 2′,5′- adenyladenosine oligonucleotides in different organs of mice. Virology, 1985, 143, 290-299.
LECCE J.G., CUMMINS J.M., RICHARDS A.B. Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon alpha. Mol. Biother., 1990, 2, 211-216.
LEE S. B., GREEN S. R., MATHEWS M. B., ESTEBAN M. Activation of the double-stranded RNA (dsRNA)-activated human protein kinase in vivo in the absence of its dsRNA binding domain. Proc. Natl. Acad. Sci. USA, 1994, 91, 10551-10555.
LEFÈVRE F., BOULAY V. A novel and atypical type one interferon gene expressed by trophoblast during early pregnancy. J. Biol. Chem., 1993, 268, 19760-19768.
LEUNG D., CAPON D., GOEDDEL D. The structure and bacterial expression of three distinct bovine interferon-beta genes. Biotechnology, 1984, 2, 458-464.
LEUNG S., QURESHI S. A., KERR I.M., DARNELL J.E., STARK G.R. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol., 1995, 15, 1312-1317.
LEVIN D.H., PETRYSHYN R., LONDON I.M. Characterization of double-stranded-RNA-activated kinase that phosphorylates alpha subunit of eukaryotic initiation factor 2 (eIF-2 alpha) in reticulocyte lysates. Proc. Natl. Acad. Sci. USA, 1980, 77, 832-836.
LI X., QIN J. Modulation of Toll-interleukin 1 receptor mediated signaling. J. Mol. Med., 2005, 83, 258-266.
LIN R., GÉNIN P., MAMANE Y., HISCOTT J. Selective DNA binding and association with the CREB binding protein coactivator contributeto differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol., 2000, 20, 6342-6353.
LIN R., HEYLBROECK C., PITHA P. M., HISCOTT J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol., 1998, 18, 2986-2996.
LIN R., MAMANE Y., HISCOTT J. Structural and functional analysis of interferon regulatory factor 3 : localization of the transactivation and autoinhibitory domains. Mol. Cell. Biol., 1999, 19, 2465-2474.
LINDENMANN J. Resistance of mice to mouse-adapted influenza A virus. Virology, 1962, 16, 203-204.
LINDENMANN J., DEUEL E., FANCONI S., HALLER O. Inborn resistance of mice to myxoviruses : macrophages express phenotype in vitro. J. Exp. Med., 1978, 147, 531-540.
LIU L., LEAMAN D.W., ROBERTS R.M. The interferon-tau genes of the giraffe, a nonbovid species. J. Interferon Cytokine Res., 1996, 16, 949-951.
LOBIGS M., MÜLLBACHER A., WANG Y., PAVY M., LEE E. Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus. J. Gen. Virol., 2003, 84, 567-572.
LODMELL D.L., ARAI Y.T., EWALT L.C. Influence of cell type and virus upon lysis of rabies virus-infected cells by antibody and complement. Arch. Virol., 1981, 70, 147-155.
LODMELL D.L., WIEDBRAUK D.L., EWALT L.C. Interferon induced within the central nervous system during infection is inconsequential as a mechanism responsible for murine resistance to street rabies virus. J. Gen. Virol., 1989, 70, 473-478.
LOPEZ S., ISLAND M. L., DROUIN J., BANDU M. T., CHRISTEFF N., DARRACQ N., BARBEY R., DOLY J., THOMAS D., NAVARRO S. Repression of virus-induced interferon A promoters by homeodomain transcription factor Ptx1. Mol. Cell. Biol., 2000, 20, 7527-7540.
LOPEZ S., REEVES R., ISLAND M. L., BANDU M. T., CHRISTEFF N., DOLY J., NAVARRO S. Silencer activity in the interferon-A gene promoters. J. Biol. Chem., 1997, 272, 22788-22799.
LUCAS M., MASHIMO T., FRENKIEL M.-P., SIMON-CHAZOTTES D., MONTAGUTELLI X., CECCALDI P.-E., GUÉNET J.-L., DESPRÈS P. Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2′-5′ oligoadenylate synthetase 1b protein. Immunol. Cell Biol., 2003, 81, 230-236.
LUTFALLA G., HOLLAND S.J., CINATO E., MONNERON D., REBOUL J., ROGERS N.C., SMITH J.M., STARK G.R., GARDINER K., MOGENSEN K.E. Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J., 1995, 14, 5100-5108.
MAEYER E.D., MAEYER-GUIGNARD J.D. Type I interferons. Int. Rev. Immunol., 1998, 17, 53-73.
MAITRA R.K., SILVERMAN R.H. Regulation of human immunodeficiency virus replication by 2′,5′-oligoadenylate-dependent RNase L. J. Virol., 1998, 72, 1146-1152.
MANIATIS T., GOODBOURN S., FISCHER J.A. Regulation of inducible and tissue-specific gene expression. Science, 1987, 236, 1237-1245.
MARCOVISTZ R., GALABRU J., TSIANG H., HOVANESSIAN A.G. Neutralization of interferon produced early during rabies virus infection in mice. J. Gen. Virol., 1986, 67, 387-390.
MARCOVISTZ R., GERMANO P. M., RIVIÈRE Y., TSIANG H., HOVANESSIAN A.G. The effect of interferon treatment in rabies prophylaxis in immunocompetent, immunosuppressed, and immunodeficient mice. J. Interferon Res., 1987, 7, 17-27.
MARCUS P.I., VAN DER HEIDE L., SEKELICK M.J. Interferon action on avian viruses. I. Oral administration of chicken interferon-alpha ameliorates Newcastle disease. J. Interferon Cytokine Res., 1999, 19, 881-885.
MARIÉ I., DURBIN J.E., LEVY D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J., 1998, 17, 6660-6669.
MARIE I., SVAB J., ROBERT N., GALABRU J., HOVANESSIAN A.G. Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J. Biol. Chem., 1990, 265, 18601-18607.
MARK D.F., LU S.D., CREASEY A.A., YAMAMOTO R., LIN L.S. Site-specific mutagenesis of the human fibroblast interferon gene. Proc. Natl. Acad. Sci. USA, 1984, 81, 5662-5666.
MASHIMO T., LUCAS M., SIMON-CHAZOTTES D., FRENKIEL M.-P., MONTAGUTELLI X., CECCALDI P.-E., DEUBEL V., GUENET J.-L., DESPRES P. A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc. Natl. Acad. Sci. USA, 2002, 99, 11311-11316.
MATSUMORI A., TOMIOKA N., KAWAI C. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. Am. Heart J., 1988, 115, 1229-1232.
MATSUMOTO M., FUNAMI K., TANABE M., OSHIUMI H., SHINGAI M., SETO Y., YAMAMOTO A., SEY T. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol., 2003, 171, 3154-3162.
MATSUMOTO M., KIKKAWA S., KOHASE M., MIYAKE K., SEYA T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun., 2002, 293, 1364-1369.
MATTEI M., TISSOT C., GONGORA C., MECHTI N. Assignment of ISG20 encoding a new interferon-induced PML nuclear bodyassociated protein, to chromosome 15q26 by in situ hybridization. Cytogenet. Cell. Genet., 1997, 79, 286-287.
McCORMACK S.J., ORTEGA L.G., DOOHAN J.P., SAMUEL C.E. Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity. Virology, 1994, 198, 92-99.
McCORMACK S.J., THOMIS D.C., SAMUEL C.E. Mechanism of interferon action : identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase. Virology, 1992, 188, 47-56.
MEAGER A., GRAVES H., BURKE D.C., SWALLOW D.M. Involvement of a gene on chromosome 9 in human fibroblast interferon production. Nature, 1979a, 280, 493-495.
MEAGER A., GRAVES H.E., WALKER J.R., BURKE D.C., SWALLOW D.M., WESTERVELD A. Somatic cell genetics of human interferon production in human-rodent cell hybrids. J. Gen. Virol., 1979b, 45, 309-321.
MEAGER A., VISVALINGAM K., DILGER P., BRYAN D., WADHWA M. Biological activity of interleukins-28 and -29 : comparison with type I interferons. Cytokine, 2005, 31, 109-118.
MEGE D., LEFEVRE F., LABONNARDIERE C. The porcine family of interferon-omega : cloning, structural analysis, and functional studies of five related genes. J. Interferon Res., 1991, 11, 341-350.
MEIER E., KUNZ G., HALLER O., ARNHEITER H. Activity of rat Mx proteins against a rhabdovirus. J. Virol., 1990, 64, 6263-6269.
MENDONÇA R.Z., PEREIRA C.A. Relationship of interferon synthesis and the resistance of mice infected with street rabies virus. Braz. J. Med. Biol. Res., 1994, 27, 691-695.
MEURS E., CHONG K., GALABRU J., THOMAS N., KERR I., WILLIAMS B., HOVANESSIAN A. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell, 1990, 62, 379-390.
MEURS E., WATANABE Y., KADEREIT S., BARBER G., KATZE M., CHONG K., WILLIAMS B., HOVANESSIAN A. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol., 1992, 66, 5805-5814.
MO C.W., CAO Y.C., LIM B.L. The in vivo and in vitro effects of chicken interferon alpha on infectious bursal disease virus and Newcastle disease virus infection. Avian Dis., 2001, 45, 389-399.
MOCHIZUKI M., NKATANI H., YOSHIDA M. Inhibitory effets of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet. Microbiol., 1994, 39, 145-152.
MÜLLER M., BRISCOE J., LAXTON C., GUSCHIN D., ZIEMIECKIA., SILVENNOINEN O., HARPURA. G., BARBIERI G., WITTHUHN B.A., SCHINDLER C. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature, 1993, 366, 129-135.
MÜLLER U., STEINHOFF U., REIS L. F., HEMMI S., PAVLOVIC J., ZINKERNAGEL R.M., AGUET M. Functional role of type I and type II interferons in antiviral defense. Science, 1994, 264, 1918-1921.
MOGENSEN K.E., LEWERENZ M., REBOUL J., LUTFALLA G., UZÉ G. The type I interferon receptor : structure, function, and evolution of a family business. J. Interferon Cytokine Res., 1999, 19, 1069-1098.
MORAES M.P., CHINSANGARAM J., BRUM M.C.S., GRUBMAN M.J. Immediate protection of swine from foot-and-mouth disease : a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine, 2003, 22, 268-279.
MOREHEAD H., JOHNSTON P.D., WETZEL R. Roles of the 29-138 disulfide bond of subtype A of human alpha interferon in its antiviral activity and conformational stability. Biochemistry, 1984, 23, 2500-2507.
MORRIS A., TOMKINS P.T., MAUDSLEY D.J. BLACKMAN M. Infection of cultured murine brain cells by Semliki Forest virus : effects of interferon-alpha beta on viral replication, viral antigen display, major histocompatibility complex antigen display and lysis by cytotoxic T lymphocytes. J. Gen. Virol., 1987, 68, 99-106.
MOOSER H., LINDENMANN J. Homologous interference by heat-inactivated influenza-B-virus absorbed on erythrocytes. Experentia, 1957, 13, 147-148.
MURPHY F.A. Rabies pathogenesis. Arch. Virol., 1977, 54, 279-297.
MUTO N.F., MARTINAND-MARI C., ADELSON M.E., SUHADOLNIK RJ. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct. J. Virol., 1999, 73, 9021-9028.
NAGANO Y., KOJIMA Y. Interference of the inactive vaccinia virus with infection of skin by the active homologous virus. C.R. Seances Soc. Biol. Fil., 1958, 152, 372-374.
NAGATA S., MANTEI N., WEISSMANN C. The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha. Nature, 1980, 287, 401-408.
NAIK S., PARANJAPE J.M., SILVERMAN R.H. RNase L dimerization in a mammalian two-hybrid system in response to 2′,5′-oligoadenylates. Nucleic Acids Res., 1998, 26, 1522-1527.
NAKAMURA K., EIZURU Y., MINAMISHIMA Y. Effect of natural human interferon-beta on the replication of human cytomegalovirus. J Med. Virol., 1988a, 26, 363-373.
NAKAMURA K., EIZURU Y., MINAMISHIMA Y. Effect of recombinant murine interferon-beta on the replication of murine cytomegalovirus. Microbiol. Immunol., 1988b, 32, 925-931.
NAKAMURA T., ASANO A., OKANO S., KO J., KON Y., WATANABE T., AGUI T. Intracellular localization and antiviral property of canine Mx proteins. J. Interferon Cytokine Res., 2005, 25, 169-173.
NARDELLI B., ZARITSKAYA L., SEMENUK M., CHO Y.H., LAFLEUR D.W., SHAH D., ULLRICH S., GIROLOMONI G., ALBANESI C., MOORE P.A. Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system. J. Immunol., 2002, 169, 4822-4830.
NÄF D., HARDIN S. E., WEISSMANN C. Multimerization of AAGTGA and GAAAGT generates sequences that mediate virus inducibility by mimicking an interferon promoter element. Proc. Natl. Acad. Sci. USA, 1991, 88, 1369-1373.
NGUYEN H., HISCOTT J., PITHA P. M. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev., 1997, 8, 293-312.
NGUYEN L., ESPERT L., MECHTI N., WILSON 3RD D. The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro. Biochemistry, 2001, 40, 7174-7179.
NILSEN T., MARONEY P., BAGLIONI C. Synthesis of (2′-5′) oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J. Virol., 1982a, 42, 1039-1045.
NILSEN T., WOOD D., BAGLIONI C. Presence of 2′,5′-oligo(A) and of enzymes that synthesize, bind, and degrade 2′,5′-oligo(A) in HeLa cell nuclei. J. Biol. Chem., 1982b, 257, 1602-1605.
NOVICK D., COHEN B., RUBINSTEIN M. The human interferon alpha/beta receptor : characterization and molecular cloning. Cell, 1994, 77, 391-400.
OLSON J.K., GIRVIN A.M., MILLER S.D. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J. Virol., 2001, 75, 9780-9789.
ORITANI K., HIROTA S., NAKAGAWA T., TAKAHASHI I., KAWAMOTO S.-I., YAMADA M., ISHIDA N., KADOYA T., TOMIYAMA Y., KINCADE P.W., MATSUZAWA Y.T lymphocytes constitutively produce an interferonlike cytokine limitin characterized as a heatandacid-stable and heparin-binding glycoprotein. Blood, 2003, 101, 178-185.
ORITANI K., KANAKURA Y. IFN-zeta/ limitin : a member of type I IFN with mild lympho-myelosuppression. J. Cell. Mol. Med., 2005, 9, 244-254.
ORITANI K., MEDINA K.L., TOMIYAMA Y., ISHIKAWA J., OKAJIMA Y., OGAWA M., YOKOTA T., AOYAMA K., TAKAHASHI I., KINCADE P.W., MATSUZAWA Y. Limitin : an interferon-like cytokine that preferentially influences B-lymphocyte precursors. Nat. Med., 2000, 6, 659-666.
ORITANI K., TOMIYAMA Y. Interferon-zeta/limitin : novel type I interferon that displays a narrow range of biological activity. Int. J. Hematol., 2004, 80, 325-331.
OWERBACH D., RUTTER W.J., SHOWS T.B., GRAY P., GOEDDEL D.V., LAWN R.M. Leukocyte and fibroblast interferon genes are located on human chromosome 9. Proc. Natl. Acad. Sci. USA, 1981, 78, 3123-3127.
PADALKO E., NUYENS D., PALMA A.D., VERBEKEN E., AERTS J.L., CLERCQ E.D., CARMELIET P., NEYTS J. The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis. Antimicrob. Agents Chemother., 2004, 48, 267-274.
PANIGRAHI P., MOHANTY S.B., MAHESHWARI R.K., FRIEDMAN R.M. Effect of cloned human interferon-alpha 2a on bovine parainfluenza-3 virus. Brief report. Arch. Virol., 1988, 98, 107-115.
PAVLOVIC J., ARZET H. A., HEFTI H. P., FRESE M., ROST D., ERNST B., KOLB E., STAEHELI P., HALLER O. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol., 1995, 69, 4506-4510.
PAVLOVIC J., ZURCHER T., HALLER O., STAEHELI P. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol., 1990, 64, 3370-3375.
PEDRETTI E., PASSERI B., AMADORI M., ISOLA P., DI PEDE P., TELERA A., VESCOVINI R., QUINTAVALLA F., PISTELLO M. Low-dose interferon-alpha treatment for feline immunodeficiency virus infection. Vet. Immunol. Immunopathol., 2006, 109, 245-254.
PEI J., SEKELLICK M.J., MARCUS P.I., CHOI I.S., COLLISSON E.W. Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness. J. Interferon Cytokine Res., 2001, 21, 1071-1077.
PERELYGIN A.A., SCHERBIK S.V., ZHULIN I.B., STOCKMAN B.M., LI Y., BRINTON M. A. Positional cloning of the murine flavivirus resistance gene. Proc. Natl. Acad. Sci. USA, 2002, 99, 9322-9327.
PERRY A.K., CHEN G., ZHENG D., TANG H., CHENG G. The host type I interferon response to viral and bacterial infections. Cell Res., 2005, 15, 407-422.
PESTKA S., KRAUSE C., WALTER M. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev., 2004, 202, 8-32.
PESTKA S., LANGER J.A., ZOON K.C., SAMUEL C.E. Interferons and their actions. Annu. Rev. Biochem., 1987, 56, 727-777.
PFEFFER L.M., BASU L., PFEFFER S.R., YANG C.H., MURTI A., RUSSELL-KARDE D., CROZE E. The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action. J. Biol. Chem., 1997, 272, 11002-11005.
PFEFFER L.M., STEBBING N., DONNER D.B. Cytoskeletal association of human alpha-interferon-receptor complexes in interferonsensitive and -resistant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA, 1987, 84, 3249-3253.
PINTO A.J., MORAHAN P.S., BRINTON M., STEWART D., GAVIN E. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J. Interferon Res., 1990, 10, 293-298.
PITHA P., AU W. Induction of interferon alpha genes expression. Sem. Virol., 1995, 6, 151-159.
PITHA P.M., SLATE D.L., RAJ N.B., RUDDLE F.H. Human beta interferon gene localization and expression in somatic cell hybrids. Mol. Cell. Biol., 1982, 2, 564-570.
PITOSSI F., BLANK A., SCHRODER A., SCHWARZ A., HUSSI P., SCHWEMMLE M., PAVLOVIC J., STAEHELI P. A functional GTPbinding motif is necessary for antiviral activity of Mx proteins. J. Virol., 1993, 67, 6726-6732.
PLATANIAS L.C., UDDIN S., COLAMONIC, O.R. Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. J. Biol. Chem., 1994, 269, 17761-17764.
PLAYER M., TORRENCE P. The 2-5A system : modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther., 1998, 78, 55-113.
PONTEN A., SICK C., WEEBER M., HALLER O., KOCHS G. Dominant-negative mutants of human MxA protein : domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J. Virol., 1997, 71, 2591-2599.
PREJEAN C., COLAMONICI O.R. Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling. Semin. Cancer. Biol., 2000, 10, 83-92.
PRICE G.E., GASZEWSKA-MASTARLARZ A., MOSKOPHIDIS D. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J. Virol., 2000, 74, 3996-4003.
QUESADA J.R., GUTTERMAN J.U. Interferons in the treatment of human neoplasms. J. Interferon Res., 1987, 7, 575-581.
QURESHI S.A., SALDITT-GEORGIEFF M., DARNELL J.E. Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. Proc. Natl. Acad. Sci. USA, 1995, 92, 3829-3833.
RADHAKRISHNAN R., WALTER L.J., HRUZA A., REICHERT P., TROTTA P.P., NAGABHUSHAN T.L., WALTER M.R. Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure, 1996, 4, 1453-1463.
RADHAKRISHNAN R., WALTER L.J., SUBRAMANIAM P.S., JOHNSON H.M., WALTER M.R. Crystal structure of ovine interferon-tau at 2.1 A resolution. J. Mol. Biol., 1999, 286, 151-162.
RAJ N., PITHA P. Two levels of regulation of beta-interferon gene expression in human cells. Proc. Natl. Acad. Sci. USA, 1983, 80, 3923-3927.
REBELLO M.C., FONSECA M.E., MARINHO J.O., REBELLO M.A. Studies on the replication of Mayaro virus grown in interferon treated cells. Mem. Inst. Oswaldo Cruz, 1994, 89, 619-623.
REBOUILLAT D., HOVNANIAN A., MARIE I., HOVANESSIAN A.G. The 100-kDa 2′,5′-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2′p5′ A molecules is composed of three homologous domains. J. Biol. Chem., 1999, 274, 1557-1565.
REICH N., EVANS B., LEVY D., FAHEY D., KNIGHT E., DARNELL J.E. Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc. Natl. Acad. Sci. USA, 1987, 84, 6394-6398.
REIS L.F., HARADA H., WOLCHOK J.D., TANIGUCHI T., VILCEK J. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J., 1992, 11, 185-193.
RICE A., DUNCAN R., HERSHEY J., KERR I. Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells. J. Virol., 1985, 54, 894-898.
RIVAS-ESTILLAA. M., SVITKIN Y., LASTRA M. L., HATZOGLOU M., SHERKER A., KOROMILAS A.E. PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone. J. Virol., 2002, 76, 10637-10653.
ROBEK M.D., BOYD B.S., CHISARI F.V. Lambda interferon inhibits hepatitis B and C virus replication. J. Virol., 2005, 79, 3851-3854.
ROBERTSEN B., TROBRIDGE G., LEONG J.A. Molecular cloning of double-stranded RNA inducible Mx genes from Atlantic salmon (Salmo salar L.). Dev. Comp. Immunol., 1997, 21, 397-412.
ROFFET P., LOPEZ S., NAVARRO S., BANDU M.T., COULOMBEL C., VIGNAL M., DOLY J., VODJDANI G. Identification of distal silencing elements in the murine interferon-A11 gene promoter. Biochem. J., 1996, 317, 697-706.
RUBINSTEIN M., LEVY W.P., MOSCHERA J.A., LAI C.Y., HERSHBERG R.D., BARTLETT R.T., PESTKA S. Human leukocyte interferon : isolation and characterization of several molecular forms. Arch. Biochem. Biophys., 1981, 210, 307-318.
RUSSELL-HARDE D., PU H., BETTS M., HARKINS R.N., PEREZ H.D., CROZE E. Reconstitution of a high affinity binding site for type I interferons. J. Biol. Chem., 1995, 270, 26033-26036.
RYAN A.M., GALLAGHER D.S., WOMACK J.E. Syntenic mapping and chromosomal localization of bovine alpha and beta interferon genes. Mamm. Genome, 1992, 3, 575-578.
RYAN A.M., GALLAGHER D.S., WOMACK J.E. Somatic cell mapping of omega and trophoblast interferon genes to bovine syntenic group U18 and in situ localization to chromosome 8. Cytogenet. Cell. Genet., 1993, 63, 6-10.
RYAN A.M., WOMACK J.E. Type I interferon genes in cattle : restriction fragment length polymorphisms, gene numbers and physical organization on bovine chromosome 8. Anim. Genet., 1993, 24, 9-16.
RYMAN K.D., KLIMSTRA W.B., NGUYEN K.B., BIRON C.A., JOHNSTON R.E. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol., 2000, 74, 3366-3378.
RYMAN K.D.,MEIER K.C., NANGLE E.M., RAGSDALE S.L., KORNEEVA N.L., RHOADS
SAHA S., RANGARAJAN P.N. Common host genes are activated in mouse brain by Japanese encephalitis and rabies viruses. J. Gen. Virol., 2003, 84, 1729-1735.
SAMUEL C. Mechanism of interferon action : phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl. Acad. Sci. USA, 1979, 76, 600-604.
SAMUEL C. E. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem., 1993, 268, 7603-7606.
SAMUEL C.E. Antiviral actions of interferons. Clin. Microbiol. Rev., 2001, 14, 778-809.
SARKAR S.N., GHOSH A., WANG H.W., SUNG S.S., SEN G.C. The nature of the catalytic domain of 2′-5′-oligoadenylate synthetases. J. Biol. Chem., 1999, 274, 25535-25542.
SATO M., HATA N., ASAGIRI M., NAKAYA T., TANIGUCHI T., TANAKA N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett., 1998, 441, 106-110.
SATO M., SUEMORI H., HATA N., ASAGIRI M., OGASAWARA K., NAKAO K., NAKAYA T., KATSUKI M., NOGUCHI S., TANAKA N., TANIGUCHI T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity, 2000, 13, 539-548.
SATO M., TANAKA N., HATA N., ODA E., TANIGUCHI T. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett., 1998, 425, 112-6.
SAWICKI D.L., SILVERMAN R.H., WILLIAMS B.R., SAWICKI S.G. Alphavirus minus-strand synthesis and persistence in mouse embryo fibroblasts derived from mice lacking RNase L and protein kinase R. J. Virol., 2003, 77, 1801-1811.
SCHAFER S.L., LIN R., MOORE P.A., HISCOTT J., PITHA P.M. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem., 1998, 273, 2714-2720.
SCHINDLER C., SHUAI K., PREZIOSO V.R., DARNELL J.E. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science, 1992, 257, 809-813.
SCHMEDT C., GREEN S.R., MANCHE L., TAYLOR D.R., MA Y., MATHEWS M.B. Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J. Mol. Biol., 1995, 249, 29-44.
SCHNEIDER-SCHAULIES S., SCHNEIDER-SCHAULIES J., SCHUSTER A., BAYER M., PAVLOVIC J., TER MEULEN V. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J. Virol., 1994, 68, 6910-6917.
SCHNORR J.J., SCHNEIDER-SCHAULIES S., SIMON-JODICKE A., PAVLOVIC J., HORISBERGER M.A., TER MEULEN V. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol., 1993, 67, 4760-4768.
SCHRÖDER M., BOWIE A.G. TLR3 in antiviral immunity : key player or bystander ? Trends Immunol., 2005, 26, 462-468.
SCHULTZ U., KASPERS B., STAEHELI P. The interferon system of non-mammalian vertebrates. Dev. Comp. Immunol., 2004, 28, 499-508.
SCHWERS A., VANDEN BROECKE C., MAENHOUDT M., BEDUIN J.M., WERENNE J., PASTORET P.P. Experimental rotavirus diarrhoea in colostrum-deprived newborn calves: assay of treatment by administration of bacterially produced human interferon (Hu-IFN alpha 2). Ann. Rech. Vet., 1985, 16, 213-218.
SEN G.C. Viruses and interferons. Annu. Rev. Microbiol., 2001, 55, 255-281.
SENDA T., SAITOH S. MITSUI Y. Refined crystal structure of recombinant murine interferon-beta at 2.15 A resolution. J. Mol. Biol., 1995, 253, 187-207.
SENDA T., SHIMAZU T., MATSUDA S., KAWANO G., SHIMIZU H., NAKAMURA K.T., MITSUI Y. Three-dimensional crystal structure of recombinant murine interferon-beta. EMBO J., 1992, 11, 3193-3201.
SENTSUI H., TAKAMI R., NISHIMORI T., MURAKAMI K., YOKOYAMA T., YOKOMIZO Y. Anti-viral effect of interferon-alpha on bovine viral diarrhea virus. J. Vet. Med. Sci., 1998, 60, 1329-1333.
SERVANT M.J., TENOEVER B., LIN R. Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function. J. Interferon Cytokine Res., 2002, 22, 49-58.
SHARP T., RAINE D., GEWERT D., JOSHI B., JAGUS R., CLEMENS M. Activation of the interferon-inducible (2′-5′) oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1. Virology, 1999, 257, 303-313.
SHEPPARD P., KINDSVOGEL W., XU W., HENDERSON K., SCHLUTSMEYER S., WHITMORE T. E., KUESTNER R., GARRIGUES U., BIRKS C., RORABACKJ., OSTRANDER C., DONG D., SHIN J., PRESNELL S., FOX B., HALDEMAN B., COOPER E., TAFT D., GILBERT T., GRANT F. J., TACKETT M., KRIVAN W., MCKNIGHT G., CLEGG C., FOSTER D., KLUCHER K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol., 2003, 4, 63-68.
SILVERMAN R., SKEHEL J., JAMES T., WRESCHNER D., KERR I. rRNA cleavage as an index of ppp(A2′p)nA activity in interferontreated encephalomyocarditis virus-infected cells. J. Virol., 1983, 46, 1051-1055.
SIMON A., FAH J., HALLER O., STAEHELI P. Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J. Virol., 1991, 65, 968-971.
SONG B., SCHMID S. A molecular motor or a regulator ? Dynamin's in a class of its own. Biochemistry, 2003, 42, 1369-1376.
SPANJAARD R. A., VAN HIMBERGEN J. A., VAN DUIN J. The cysteines in position 1 and 86 of rat interferon-alpha 1 are indispensable for antiviral activity. FEBS Lett., 1989, 249, 186-188.
SPENCER T., BAZER F. Conceptus signals for establishment and maintenance of pregnancy. Reprod. Biol. Endocrinol., 2004, 2, 49.
STAEHELI P. Interferon-induced proteins and the antiviral state. Adv. Virus Res., 1990, 38, 147-200.
STAEHELI P., PITOSSI F., PAVLOVIC J. Mx proteins : GTPases with antiviral activity. Trends Cell. Biol., 1993, 3, 268-272.
STARK G.R., KERR I. M., WILLIAMS B.R., SILVERMAN R.H., SCHREIBER R.D. How cells respond to interferons. Annu. Rev. Biochem., 1998, 67, 227-264.
STEED V.P., Improved survival of four cats infected with feline leukemia virus after oral administration of interferon. Feline Parct., 1987, 17, 24-30.
STEWART M.J., BLUM M. A., SHERRY B. PKR's protective role in viral myocarditis. Virology, 2003, 314, 92-100.
STOJDL D.F., ABRAHAM N., KNOWLES S., MARIUS R., BRASEY A., LICHTY B.D., BROWN E.G., SONENBERG N., BELL J. C. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J. Virol., 2000, 74, 9580-9585.
SUMPTER R., LOO Y.-M., FOY E., LI K., YONEYAMA M., FUJITA T., LEMON S.M., GALE M. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol., 2005, 79, 2689-2699.
TAIRA O., SUZUKI M., TAKEUCHI Y., ARAMAKI Y., SAKURAI I., WATANABE T., MOTOKAWA K., ARAI S., SATO H., MAEHAR N. Expression of feline interferon-alpha subtypes in Esherichia coli, and their antiviral activity and animal species specificity. J. Vet. Med. Sci., 2005, 67, 543-545.
TAKEDA K., AKIRA S. Toll-like receptors in innate immunity. Int. Immunol., 2005, 17, 1-14.
TALPAZ M., KANTARJIAN H.M., KURZROCK R. GUTTERMAN J. Therapy of chronic myelogenous leukemia : chemotherapy and interferons. Semin. Hematol., 1988, 25, 62-73.
TAVERNIER J., DERYNCK R. FIERS W. Evidence for a unique human fibroblast interferon (IFN-beta 1) chromosomal gene, devoid of intervening sequences. Nucleic Acids Res., 1981, 9, 461-471.
TAYLOR D.R., PUIG M., DARNELL M. E.R., MIHALIK K., FEINSTONE S.M. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol., 2005, 79, 6291-6298.
TENOEVER B., SERVANT M., GRANDVAUX N., LIN R., HISCOTT J. Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J. Virol., 2002, 76, 3659-3669.
THANOS D., MANIATIS T. The high mobility group protein HMG 1(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell, 1992, 71, 777-789.
THANOS D., MANIATIS T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell, 1995, 83, 1091-1100.
TAIRA O., SUZUKI M., TAKEUCHI Y., ARAMAKI Y., SAKURAI I., WATANABE T., MOTOKAWA K., ARAI S., SATO H., MEHARA N. Expression of feline interferon-alpha subtypes in Esherichia coli, and their antiviral activity and animal species specificity. J. Vet. Med. Sci., 2005, 67, 543-545.
TOMPKINS M.D., CUMMINS J.M. Response of feline leukemia virus-induced nonregenerative anemia to oral administration of an interferon-containing preparation. Feline Pract., 1982, 12, 6-15.
TOVEY M.G., STREULI M., GRESSER I., GUGENHEIM J., BLANCHARD B., GUYMARHO J., VIGNAUX F., GIGOU M. Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc. Natl. Acad. Sci. USA, 1987, 84, 5038-5042.
TROBRIDGE G.D. LEONG J.A. Characterization of a rainbow trout Mx gene. J. Interferon Cytokine Res., 1995, 15, 691-702.
TROTTIER M.D., PALIAN B.M., REISS C.S. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology, 2005, 333, 215-225.
TRUEBLOOD M.S., MANJARA J. Response of bovine viruses to interferon. Cornell Vet., 1972, 62, 3-12.
TURAN K., MIBAYASHI M., SUGIYAMA K., SAITO S., NUMAJIRI A., NAGATA K. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res., 2004, 32, 643-652.
UEMATSU S., SATO S., YAMAMOTO M., HIROTANI T., KATO H., TAKESHITA F., MATSUDA M., COBAN C., ISHII K. J., KAWAI T., TAKEUCHI O. AKIRA S. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-alpha induction. J. Exp. Med., 2005, 201, 915-923.
UZÉ G., LUTFALLA G., GRESSER I. Genetic transfer of a functional human interferon alpha receptor into mouse cells : cloning and expression of its cDNA. Cell, 1990, 60, 225-234.
VAN DER KORPUT J.A., HILKENS J., KROEZEN V., ZWARTHOFF E.C. TRAPMAN J. Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. J Gen Virol, 1985, 66, 493-502.
VAN PESCH V., LANAYA H., RENAULD J.-C., MICHIELS T. Characterization of the murine alpha interferon gene family. J. Virol., 2004, 78, 8219-8228.
VAN PESCH V., MICHIELS T. Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J. Biol. Chem., 2003, 278, 46321-46328.
VANDAELE E. L'Interferon omega augmente la survie lors de viroses graves. Point Vet., 2002, 33, 16-17.
VANDEN-BROECKE C., PFEFFER L.M. Characterization of interferon-alpha binding sites on human cell lines. J. Interferon Res., 1988, 8, 803-811.
VASSILEVA G., CHEN S.-C., ZENG M., ABBONDANZO S., JENSEN K., GORMAN D., BAROUDY B.M., JIANG Y., MURGOLO N., LIRA S.A. Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in mice. J. Immunol., 2003, 170, 5748-5755.
VEALS S.A., MARIA T.S., LEVY D.E. Two domains of ISGF3 gamma that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity. Mol. Cell. Biol., 1993, 13, 196-206.
VEALS S.A., SCHINDLER C., LEONARD D., FU X.Y., AEBERSOLD R., DARNELL J.E., LEVY D.E. Subunit of an alpha-interferonresponsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell. Biol., 1992, 12, 3315-3324.
VELAN B., COHEN S., GROSFELD H., LEITNER M., SHAFFERMAN A. Bovine interferon alpha genes. Structure and expression. J. Biol. Chem, 1985, 260, 5498-5504.
VELAZQUEZ L., FELLOUS M., STARK G.R., PELLEGRINI S. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell, 1992, 70, 313-322.
VODJDANI G., COULOMBEL C., DOLY J. Structure and characterization of a murine chromosomal fragment containing the interferon beta gene. J. Mol. Biol., 1988, 204, 221-231.
WALTER M.R., BURDENS R., NAGABHUSHAN T.L., WILLIAMS B.R., HERBERMAN R.B., DINARELLO C.A., BORDEN E.C., TROTTA P.P., PESTKA S., PFEFFER L.M. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon. Cancer Biother. Radiopharm., 1998, 13, 143-154.
WATHELET M.G., LIN C.H., PAREKH B.S., RONCO L.V., HOWLEY P.M., MANIATIS T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell., 1998, 1, 507-518.
WEAVER B.K., KUMAR K.P., REICH N.C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol., 1998, 18, 1359-1368.
WEBER F., HALLER O., KOCHS G. MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes. J. Virol., 2000, 74, 560-563.
WEINGARTL H.M., DERBYSHIRE J.B. The induction and characterization of natural porcine interferons alpha and beta. Can. J. Vet. Res., 1990, 54, 349-354.
WEISS R.C., COX N.R., OOSTROMRAM T. Effect of interferon or propionibacterium acnes on the course of experimentally induced feline infectious peritonitis in specific-pathogen-free and randomsource cats. Am. J. Vet. Res., 1990, 51, 726-733.
WEISS R.C., OOSTROM-RAM T. Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro. Vet. Microbiol. 1989, 20, 255-265.
WEISS R.C., TOIVIO-KINNUCAN M. Inhibition of feline infectious virus replication by recombinant human leukocyte (alpha) interferon and feline fibroblastic (beta) interferon. Am. J. Vet. Res., 1988, 49, 1329-1335.
WESSELY R., KLINGEL K., KNOWLTON K. U., KANDOLF R. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling : implications for mortality and early viral replication. Circulation, 2001, 103, 756-761.
WETZEL R. Assignment of the disulphide bonds of leukocyte interferon. Nature, 1981, 289, 606-607.
WETZEL R., PERRY L.J., ESTELL D.A., LIN N., LEVINE H.L., SLINKER B., FIELDS F., ROSS M.J., SHIVELY J. Properties of a human alpha-interferon purified from E. coli extracts. J. Interferon Res., 1981, 1, 381-390.
WHALEY A.E., MEKA C.S., HARBISON L.A., HUNT J.S., IMAKAWA K. Identification and cellular localization of unique interferon mRNA from human placenta. J. Biol. Chem., 1994, 269, 10864-10868.
WHITE L.J., WANG J.G., DAVIS N.L., JOHNSTON R.E. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis : effect of an attenuating mutation in the 5′ untranslated region. J. Virol., 2001, 75, 3706-3018.
WIENS M., KUUSKSALU A., KELVE M., MULLER W.E. Origin of the interferon-inducible (2′-5′)oligoadenylate synthetases : cloning of the (2′-5′)oligoadenylate synthetase from the marine sponge Geodia cydonium. FEBS Lett., 1999, 462, 12-18.
WING T.L., GOOD R.A., TRANG L.Q., ENGELMAN R.W., DAY N.K. Remission of leukemia and loss of feline leukemia virus in cats injected wit Staphyloccocus protein A: Association with increased circulating interferon and complement-dependent cytotoxic antibody. Proc. Natl. Acad. Sci. USA, 1984, 81, 6471-6475.
WITT P.L., MARIE I., ROBERT N., IRIZARRY A., BORDEN E.C., HOVANESSIAN A.G. Isoforms p69 and p100 of 2′,5′-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro. J. Interferon Res., 1993, 13, 17-23.
YAN H., KRISHNAN K., GREENLUND A.C., GUPTA S., LIM J.T., SCHREIBER R.D., SCHINDLER C.W., KROLEWSKI J.J. Phosphorylated interferon-alpha receptor I subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J., 1996, 15, 1064-1074.
YANG Y.L., REIS L.F., PAVLOVIC J., AGUZZI A., SCHÄFER R., KUMAR A., WILLIAMS B.R., AGUET M., WEISSMANN C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J., 1995, 14, 6095-6106.
YEE L.J., KNAPP S., BURGNER D., HENNIG B.J.W., FRODSHAM A.J., WRIGHT M., THOMAS H.C., HILL A.V.S., THURSZ M.R. Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection. Genes Immun., 2004, 5, 183-187.
YIE J., LIANG S., MERIKA M., THANOS D. Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter. Mol. Cell. Biol., 1997, 17, 3649-3662.
YONEYAMA M., KIKUCHI M., NATSUKAWA T., SHINOBU N., IMAIZUMI T., MIYAGISHI M., TAIRA K., AKIRA S. FUJITA T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol., 2004, 5, 730-737.
YONEYAMA M., SUHARA W., FUKUHARA Y., FUKUDA M., NISHIDA E., FUJITA T. Direct triggering of the type I interferon system by virus infection : activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J., 1998, 17, 1087-1095.
YONEYAMA M., SUHARA W., FUKUHARA Y., SATO M., OZATO K., FUJITA T. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. (Tokyo), 1996, 120, 160-169.
YOUNGNER J.S., SCOTT A.W. Relation of interferon synthesis to abortive replication of Newcastle disease virus in L cells. J. Virol., 1968, 2, 81-82.
YOUNGNER J.S., SCOTT A.W., HALLUM J.V., STINEBRING W.R. Interferon production by inactivated Newcastle disease virus in cell cultures and in mice. J. Bacteriol., 1966, 92, 862-868.
ZAMANIAN-DARYOUSH M., MOGENSEN T.H., DIDONATO J.A., WILLIAMS B.R. NF-kappaB activation by double-stranded-RNAactivated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol. Cell. Biol., 2000, 20, 1278-90.
ZEIDNER N.S., MATHIASON-DUBARD C.K., HOOVER E.A. Reversal of feline leukemia virus infection by adoptive transfer of lectin/interleukin-2-activated lymphocytes, interferon-alpha, and zidovudine. J. Immunotherap., 1993, 14, 22-32.
ZEIDNER N.S., MYLES M.H., MATHIASON-DUBARD C.K., DREITZ M.J., MULLINS J.I., HOOVER E.A. Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome. Antimicrob. Agents Chemother., 1990, 34, 1749-1756.
ZHAO H., DE B.P., DAS T., BANERJEE A.K. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology, 1996, 220, 330-338.
ZHOU A., PARANJAPE J.M., DER S.D., WILLIAMS B.R., SILVERMAN R.H. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology, 1999, 258, 435-440.
ZILBERSTEIN A., FEDERMAN P., SHULMAN L., REVEL M. Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L cells. FEBS Lett., 1976, 68, 119-124.